- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06849674
Efficacy and Safety of Platelet-Rich Plasma As an Intraoperative Holding Solution in Hair Transplantation
February 26, 2025 updated by: karem Taha ibrahim khalil, Benha University
The goal of this study is to determine the efficacy of using platelet-rich plasma (PRP) versus 0.9% normal saline as a storage solution during follicular unit extraction (FUE) hair transplantation.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Study Type
Interventional
Enrollment (Actual)
60
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Qalyubia
-
Benha, Qalyubia, Egypt, 13511
- Dermatology, Venereology and Andrology Faculty of Medicine- Benha University
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Child
- Adult
- Older Adult
Accepts Healthy Volunteers
No
Description
Inclusion Criteria:
- Male patients who have androgenetic alopecia
- Patients who are interested in having their hair transplanted
Exclusion Criteria:
- Individuals with comorbidities
- History of keloids or hypertrophic scarring
- Low donor area density
- Other causes of alopecia
- Scalp infections
- Patients with a bleeding tendency
- Patients on anticoagulant therapy
- Patients who are HIV-positive or Hepatitis B- or C-positive
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Double
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Active Comparator: Saline group
in this group, hair grafts will be stored in Normal saline 0.9% before transplantation.
|
Hair grafts will be immersed in normal saline solution before transplantation.
|
|
Experimental: Platelet-rich plasma group
In this group, hair grafts will be stored in Platelet-rich plasma before transplantation.
|
Hair grafts will be immersed in autologous Platelwt-richh plasma(PRP) before transplantation.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Change in Hair density
Time Frame: 12 weeks after hair transplantation
|
Hair density (the number of hairs per square centimeter) will be measured using a trichoscope and digital photography in the recipient area.
|
12 weeks after hair transplantation
|
|
Percentage of Hair Growth
Time Frame: 12 weeks after hair transplantation
|
The percentage of graft survival will be assessed by comparing the number of transplanted hairs to the number of hairs that have grown in the recipient area using trichoscopic analysis and digital photography.
The formula used will be: (number of grown hairs/number of transplanted hairs) x100%
|
12 weeks after hair transplantation
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Patient satisfaction score
Time Frame: 12weeks after hair translantation
|
Patient satisfaction will be assessed using Likert scale from 1 to 5 regarding aesthetic results, hair density, and natural appearance.
Higher scores indicate greater satisfaction.
|
12weeks after hair translantation
|
|
Incidence of Postoperative complications
Time Frame: within 1 month after hair transplantation
|
The number and type of complications, including infection,graft necrosis, excessive shedding, and scalp irritation, will be documented.
The severity of complications will be assessed using clinical examination and patient reports
|
within 1 month after hair transplantation
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Study Director: Amany I Mustafa, MD, Dermatology, Venereology and Andrology Faculty of Medicine- Benha University
- Study Director: Ahmed I Abdulkhaleq, MBBCh, Dermatology, Venereology and Andrology Faculty of Medicine- Benha University
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
May 23, 2023
Primary Completion (Actual)
November 28, 2024
Study Completion (Actual)
November 28, 2024
Study Registration Dates
First Submitted
February 19, 2025
First Submitted That Met QC Criteria
February 23, 2025
First Posted (Actual)
March 25, 2025
Study Record Updates
Last Update Posted (Actual)
March 25, 2025
Last Update Submitted That Met QC Criteria
February 26, 2025
Last Verified
February 1, 2025
More Information
Terms related to this study
Other Study ID Numbers
- PRP in hair transplantation
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
product manufactured in and exported from the U.S.
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Hair Transplantation
-
Nanfang Hospital of Southern Medical UniversityCompletedHair TransplantationChina
-
Biointelligent Technology Systems SLCompletedTHERAVEX® REGENERA Tissue Care Plus for Hair Regeneration and Follicular Microenvironment ModulationAndrogenetic Alopecia | Alopecia | Hair Loss | Hair Transplantation | Non-scarring AlopeciaSpain
-
Alexandria UniversityCompleted
-
Nanfang Hospital, Southern Medical UniversityNot yet recruitingLocalized Scleroderma | Fat Grafting | Hair Transplantation
-
Dong-A PharmaceuticalGlobal Medical Research Center Co., Ltd.CompletedHair Damage | Hair Health | Hair StrengthSouth Korea
-
Two Lines LLCCitruslabsCompletedHair Aging | Hair GrayingUnited States
-
NovoBliss Research Pvt LtdOrgenetics, Inc.CompletedDry Skin | Dry Hair | Hair Falling | Thin Hair | Brittle HairIndia
-
Syneron MedicalUnknownExcess Hair GrowthUnited States
-
University of ChicagoNot yet recruitingTrichotillomania | Trichotillomania (Hair-Pulling Disorder) | Hair Pulling | Hair Pulling Disorder | Hair-Pulling Disorder
-
Restore Biologics Holdings, Inc. dba XtresséActive, not recruitingAlopecia | Hair Loss | Thinning Hair | Thin HairUnited States
Clinical Trials on Saline
-
Johns Hopkins UniversityCystic Fibrosis FoundationCompletedCystic Fibrosis
-
Children's Hospital Los AngelesThrasher Research Fund; UCSF Benioff Children's Hospital OaklandCompleted
-
University Hospital Inselspital, BerneCompletedCardiovascular Diseases | Valvular Heart DiseaseSwitzerland
-
Imam Abdulrahman Bin Faisal UniversityUnknownOtorhinolaryngologic Diseases | RhinosinusitisSaudi Arabia
-
Aalborg UniversityThe Danish Rheumatism AssociationCompleted
-
Dr. Michael FlavinWithdrawn
-
Szpital im. Św. Jadwigi ŚląskiejCompleted
-
Makassed General HospitalCompletedLength of Hospital StayLebanon
-
University of Washington, the Collaborative Health...Cystic Fibrosis FoundationCompleted
-
Qassim UniversityCompletedApical Periodontitis | Post Operative Pain | Dental Pulp NecrosesSaudi Arabia